LETTER TO THE EDITOR
Response to: Is newly diagnosed diabetes a stronger risk factor than pre-existing diabetes for COVID-19 severity?
对以下问题的回应:与既往糖尿病相比，新诊断的糖尿病是否是新冠肺炎严重程度的更强危险因素?
Giuseppe Lippi,
Giuseppe Lippi
Section of Clinical Biochemistry, Department of Neuroscience, Biomedicine and Movement, University of Verona, Verona, Italy
Search for more papers by this author Fabian Sanchis-Gomar,
Fabian Sanchis-Gomar
Department of Physiology, Faculty of Medicine, University of Valencia and INCLIVA Biomedical Research Institute, Valencia, Spain
Division of Cardiovascular Medicine, Stanford University School of Medicine, Stanford, California, USA
Search for more papers by this author Brandon Michael Henry,
Corresponding Author
Brandon Michael Henry
Cardiac Intensive Care Unit, The Heart Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA
Correspondence
Brandon Michael Henry, The Heart Institute, Cincinnati Children's Hospital Medical Center, 3333 Burnet Ave., Cincinnati, OH 45229, USA.
Email: [email protected]
Search for more papers by this author
Giuseppe Lippi,
Giuseppe Lippi
Section of Clinical Biochemistry, Department of Neuroscience, Biomedicine and Movement, University of Verona, Verona, Italy
Search for more papers by this author Fabian Sanchis-Gomar,
Fabian Sanchis-Gomar
Department of Physiology, Faculty of Medicine, University of Valencia and INCLIVA Biomedical Research Institute, Valencia, Spain
Division of Cardiovascular Medicine, Stanford University School of Medicine, Stanford, California, USA
Search for more papers by this author Brandon Michael Henry,
Corresponding Author
Brandon Michael Henry
Cardiac Intensive Care Unit, The Heart Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA
Correspondence
Brandon Michael Henry, The Heart Institute, Cincinnati Children's Hospital Medical Center, 3333 Burnet Ave., Cincinnati, OH 45229, USA.
Email: [email protected]
Search for more papers by this author
First published: 30 October 2020
No abstract is available for this article.
REFERENCES
- 1Sathish T, de Mello GT, Cao Y. Is newly diagnosed diabetes a stronger risk factor than pre-existing diabetes for COVID-19 severity?. J Diabetes. 2020. https://doi.org/10.1111/1753-0407.13125.
- 2Aggarwal G, Lippi G, Lavie CJ, Henry BM, Sanchis-Gomar F. Diabetes mellitus association with coronavirus disease 2019 (COVID-19) severity and mortality: a pooled analysis. J Diabetes. 2020; 12(11): 851-855.
- 3Yao RQ, Ren C, Wu GS, Zhu YB, Xia ZF, Yao YM. Is intensive glucose control bad for critically ill patients? A systematic review and meta-analysis. Int J Biol Sci. 2020; 16(9): 1658-1675.
- 4Lee MH, Wong C, Ng CH, Yuen DCW, Lim AYL, Khoo CM. Effects of hyperglycaemia on complications of COVID-19: a meta-analysis of observational studies. Diabetes Obes Metab. 2020. https://doi.org/10.1111/dom.14184. [Epub ahead of print].
- 5Lampasona V, Secchi M, Scavini M, et al. Antibody response to multiple antigens of SARS-CoV-2 in patients with diabetes: an observational cohort study. Diabetologia. 2020; 1-11. https://doi.org/10.1007/s00125-020-05284-4. [Epub ahead of print].
- 6Sing A. Hyperglycemia without diabetes and new-onset diabetes are both associated with poorer outcomes in COVID-19. Diab Res Clin Pract. 2020; 167:108382.
- 7Brufsky A. Hyperglycemia, hydroxychloroquine, and the COVID-19 pandemic. J Med Virol. 2020 Jul; 92(7): 770-775. https://doi.org/10.1002/jmv.25887.
